Literature DB >> 18094332

Sox18 and Sox7 play redundant roles in vascular development.

Solei Cermenati1, Silvia Moleri, Simona Cimbro, Paola Corti, Luca Del Giacco, Roberta Amodeo, Elisabetta Dejana, Peter Koopman, Franco Cotelli, Monica Beltrame.   

Abstract

Mutations in SOX18 cause the human hypotrichosis-lymphedema-telangiectasia (HLT) syndrome. Their murine counterparts are the spontaneous ragged mutants, showing combined defects in hair follicle, blood vessel, and lymphatic vessel development. Mice null for Sox18 display only mild coat defects, suggesting a dominant-negative effect of Sox18/ragged mutations and functional redundancy between Sox18 and other Sox-F proteins. We addressed this point in zebrafish. The zebrafish homologs of Sox18 and of Sox7 are expressed in angioblasts and in the endothelial component of nascent blood vessels in embryos. Knockdown of either gene, using moderate doses of specific morpholinos, had minimal effects on vessels. In contrast, simultaneous knockdown of both genes resulted in multiple fusions between the major axial vessels. With combined use of transgenic lines and molecular markers, we could show that endothelial cells are specified, but fail to acquire a correct arteriovenous identity. Venous endothelial cell differentiation was more severely affected than arterial. Thus, sox7 and sox18 play redundant but collectively essential roles in the establishment of proper arteriovenous identity in zebrafish. Our data suggest that a defect in arteriovenous identity could be responsible for the formation of telangiectases in patients with HLT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094332     DOI: 10.1182/blood-2007-07-100412

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  72 in total

1.  Shh maintains dermal papilla identity and hair morphogenesis via a Noggin-Shh regulatory loop.

Authors:  Wei-Meng Woo; Hanson H Zhen; Anthony E Oro
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  Genome-scale study of transcription factor expression in the branching mouse lung.

Authors:  John C Herriges; Lan Yi; Elizabeth A Hines; Julie F Harvey; Guoliang Xu; Paul A Gray; Qiufu Ma; Xin Sun
Journal:  Dev Dyn       Date:  2012-07-20       Impact factor: 3.780

3.  Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.

Authors:  Bing Li; Zhiping Ge; Shipeng Song; Shengbin Zhang; Hong Yan; Boyun Huang; Yangde Zhang
Journal:  Pathol Oncol Res       Date:  2012-07-10       Impact factor: 3.201

Review 4.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 5.  Vascular development in the zebrafish.

Authors:  Aniket V Gore; Kathryn Monzo; Young R Cha; Weijun Pan; Brant M Weinstein
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

6.  The regulation of SOX7 and its tumor suppressive role in breast cancer.

Authors:  Daniel B Stovall; Meimei Wan; Lance D Miller; Paul Cao; Dejan Maglic; Qiang Zhang; Martha R Stampfer; Wennuan Liu; Jianfeng Xu; Guangchao Sui
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

7.  SoxF factors induce Notch1 expression via direct transcriptional regulation during early arterial development.

Authors:  Ivy Kim-Ni Chiang; Martin Fritzsche; Cathy Pichol-Thievend; Alice Neal; Kelly Holmes; Anne Lagendijk; Jeroen Overman; Donatella D'Angelo; Alice Omini; Dorien Hermkens; Emmanuelle Lesieur; Ke Liu; Indrika Ratnayaka; Monica Corada; George Bou-Gharios; Jason Carroll; Elisabetta Dejana; Stefan Schulte-Merker; Benjamin Hogan; Monica Beltrame; Sarah De Val; Mathias Francois
Journal:  Development       Date:  2017-06-15       Impact factor: 6.868

8.  Sox7 is regulated by ETV2 during cardiovascular development.

Authors:  Ann N Behrens; Claudia Zierold; Xiaozhong Shi; Yi Ren; Naoko Koyano-Nakagawa; Daniel J Garry; Cindy M Martin
Journal:  Stem Cells Dev       Date:  2014-06-17       Impact factor: 3.272

9.  Divergence of zebrafish and mouse lymphatic cell fate specification pathways.

Authors:  Andreas van Impel; Zhonghua Zhao; Dorien M A Hermkens; M Guy Roukens; Johanna C Fischer; Josi Peterson-Maduro; Henricus Duckers; Elke A Ober; Philip W Ingham; Stefan Schulte-Merker
Journal:  Development       Date:  2014-02-12       Impact factor: 6.868

10.  Early growth response protein 1 acts as an activator of SOX18 promoter.

Authors:  Isidora Petrovic; Natasa Kovacevic-Grujicic; Milena Stevanovic
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.